Immunovant, Inc.
IMVTNasdaqCIK 1764013HealthcareFiscal year ends Mar 31
Reports and events: 143 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0321:05 ET | 8-K | 5.07 Shareholder vote results | 0001764013-26-000106 |
| 2026-08-0611:29 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001764013-26-000101 |
| 2026-08-0611:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-26-000100 |
| 2026-07-2220:10 ET | DEF 14A | Proxy statementPeriod 2026-09-02 | 0001764013-26-000092 |
| 2026-05-2011:28 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001764013-26-000064 |
| 2026-05-2011:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-26-000062 |
| 2026-02-0612:24 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001764013-26-000011 |
| 2026-02-0612:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-26-000010 |
| 2025-12-1221:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-317577 |
| 2025-12-1217:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-045411 |
| 2025-12-1111:39 ET | 8-K | 8.01 Other events | 0001193125-25-314994 |
| 2025-11-2113:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001764013-25-000153 |
| 2025-11-1012:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001764013-25-000149 |
| 2025-11-1012:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-25-000148 |
| 2025-09-0317:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-25-000136 |
| 2025-08-2820:13 ET | 8-K | 5.07 Shareholder vote results | 0001764013-25-000132 |
| 2025-08-1111:29 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001764013-25-000129 |
| 2025-08-1111:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-25-000128 |
| 2025-07-2920:57 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001764013-25-000121 |
| 2025-07-0920:54 ET | DEF 14A | Proxy statementPeriod 2025-08-27 | 0001764013-25-000103 |
| 2025-05-2911:30 ET | 10-K | Annual reportPeriod 2025-03-31 | 0001764013-25-000092 |
| 2025-05-2911:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-25-000091 |
| 2025-04-2111:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-25-000078 |
| 2025-04-2107:54 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-014645 |
| 2025-03-1911:51 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-25-000037 |
| 2025-02-0611:45 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001764013-25-000026 |
| 2025-02-0611:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-25-000024 |
| 2025-01-2422:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-012329 |
| 2025-01-1516:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-25-001185 |
| 2025-01-1413:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-25-000009 |
| 2025-01-1313:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-25-000007 |
| 2024-11-0711:49 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001764013-24-000184 |
| 2024-11-0711:42 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-24-000183 |
| 2024-09-0911:40 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-24-000162 |
| 2024-08-1320:12 ET | 8-K | 5.07 Shareholder vote results | 0001764013-24-000150 |
| 2024-08-0620:19 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001764013-24-000148 |
| 2024-08-0620:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-24-000147 |
| 2024-06-2610:56 ET | DEF 14A | Proxy statementPeriod 2024-08-12 | 0001764013-24-000114 |
| 2024-05-2920:36 ET | 10-K | Annual reportPeriod 2024-03-31 | 0001764013-24-000109 |
| 2024-05-2920:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-24-000107 |
| 2024-02-1212:05 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001764013-24-000026 |
| 2024-02-1212:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-24-000025 |
| 2024-01-0913:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001764013-24-000003 |
| 2023-12-2021:37 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-23-000159 |
| 2023-11-2812:43 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-23-000150 |
| 2023-11-0912:13 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001764013-23-000133 |
| 2023-11-0912:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001764013-23-000131 |
| 2023-10-0417:19 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-23-046991 |
| 2023-09-2821:23 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-245815 |
| 2023-09-2611:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001764013-23-000114 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.